Cargando…
Sorafenib as first-line treatment for patients with primary hepatocellular carcinoma: an outcome evaluation
OBJECTIVE: To evaluate the clinical outcomes following first-line treatment with sorafenib in patients with primary hepatocellular carcinoma (HCC). METHODS: This retrospective cohort study enrolled patients with primary HCC that had been treated with sorafenib. Their data were collected from the hos...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291016/ https://www.ncbi.nlm.nih.gov/pubmed/37314298 http://dx.doi.org/10.1177/03000605231179928 |